Evidence map›Paper›PMID 28158858›Full record

ArticleNucleic acids research2017

Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization.

Madison B Adolph, Anjuman Ara, Yuqing Feng, Cristina J Wittkopp, Michael Emerman, James S Fraser, Linda Chelico

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Evolvability of cancer-associated genes under APOBEC3A/B selection.bioRxiv : the preprint server for biology · 2023
    Article
  8. Article
  9. Article
  10. The current toolbox for APOBEC drug discovery.Trends in pharmacological sciences · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Madison B AdolphDepartment of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Anjuman AraDepartment of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Yuqing FengDepartment of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Cristina J WittkoppDepartment of Microbiology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Michael EmermanDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
James S FraserDepartment of Bioengineering and Therapeutic Science and California Institute for Quantitative Biology, University of California, San Francisco, San Francisco, CA, USA.
Linda ChelicoDepartment of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
University of Saskatchewan · CAFred Hutch Cancer Center · USUniversity of California, San Francisco · US

Funding

X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
VPR AND HIV INFECTIONR01AI030927 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI EMERMAN, MICHAEL · 1991 to 2020
$5.3M
CIHR MOP137090NIAID NIH HHS R01 AI030927NIGMS NIH HHS P50 GM082250
6 · The paper itself

Abstract

The seven APOBEC3 (A3) enzymes in primates restrict HIV/SIV replication to differing degrees by deaminating cytosine in viral (-)DNA, which forms promutagenic uracils that inactivate the virus. A polymorphism in human APOBEC3C (A3C) that encodes an S188I mutation increases the enzymatic activity of the protein and its ability to restrict HIV-1, and correlates with increased propensity to form dimers. However, other hominid A3C proteins only have an S188, suggesting they should be less active like the common form of human A3C. Nonetheless, here we demonstrate that chimpanzee and gorilla A3C have approximately equivalent activity to human A3C I188 and that chimpanzee and gorilla A3C form dimers at the same interface as human A3C S188I, but through different amino acids. For each of these hominid A3C enzymes, dimerization enables processivity on single-stranded DNA and results in higher levels of mutagenesis during reverse transcription in vitro and in cells. For increased mutagenic activity, formation of a dimer was more important than specific amino acids and the dimer interface is unique from other A3 enzymes. We propose that dimerization is a predictor of A3C enzyme activity.

Indexed as

AnimalsCytidine DeaminaseDNA, Single-StrandedGorilla gorillaHumansMutagenesisPan troglodytesProtein MultimerizationProtein Structure, SecondaryAPOBEC3C protein, humanCytidine DeaminaseDNA, Single-Stranded

Identifiers

PMID28158858
PMCPMC5389708
OpenAlexW2584562655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.